GENOSS SES

· Genoss Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GENOSS SES, covering 2025-09-16 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)